DK1636389T3 - Plasmidfri klon af E. coli-stammen DSM 6601 - Google Patents
Plasmidfri klon af E. coli-stammen DSM 6601Info
- Publication number
- DK1636389T3 DK1636389T3 DK04740297T DK04740297T DK1636389T3 DK 1636389 T3 DK1636389 T3 DK 1636389T3 DK 04740297 T DK04740297 T DK 04740297T DK 04740297 T DK04740297 T DK 04740297T DK 1636389 T3 DK1636389 T3 DK 1636389T3
- Authority
- DK
- Denmark
- Prior art keywords
- plasmid
- coli strain
- strain dsm
- free clone
- clone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10328669A DE10328669B4 (de) | 2003-06-26 | 2003-06-26 | Plasmidfreier Klon des E. coli Stammes DSM 6601 |
| PCT/EP2004/006886 WO2004113575A1 (de) | 2003-06-26 | 2004-06-25 | Plasmidfreier klon des e. coli-stammes dsm 6601 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1636389T3 true DK1636389T3 (da) | 2009-02-16 |
Family
ID=33520989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04740297T DK1636389T3 (da) | 2003-06-26 | 2004-06-25 | Plasmidfri klon af E. coli-stammen DSM 6601 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7993902B2 (pl) |
| EP (1) | EP1636389B1 (pl) |
| JP (1) | JP2009514506A (pl) |
| KR (1) | KR100654029B1 (pl) |
| CN (1) | CN100395328C (pl) |
| AT (1) | ATE412072T1 (pl) |
| AU (1) | AU2004249888B2 (pl) |
| CA (1) | CA2496080C (pl) |
| DE (2) | DE10328669B4 (pl) |
| DK (1) | DK1636389T3 (pl) |
| ES (1) | ES2314407T3 (pl) |
| HK (1) | HK1079994B (pl) |
| IL (1) | IL167067A (pl) |
| NZ (1) | NZ541192A (pl) |
| PL (1) | PL1636389T3 (pl) |
| PT (1) | PT1636389E (pl) |
| SI (1) | SI1636389T1 (pl) |
| TW (1) | TWI284150B (pl) |
| WO (1) | WO2004113575A1 (pl) |
| ZA (1) | ZA200501194B (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102229898B (zh) * | 2011-05-06 | 2012-11-14 | 首都医科大学附属北京友谊医院 | 用于治疗菌群失调症菌群紊乱症的大肠埃希氏菌、制剂及其制备方法 |
| CN113046285A (zh) | 2012-04-06 | 2021-06-29 | 康奈尔大学 | 用于稳健的体液及细胞免疫应答的亚单位疫苗递送平台 |
| CN103740747A (zh) * | 2014-02-08 | 2014-04-23 | 扬州大学 | 一种使用自杀性载体去除大肠杆菌Nissle菌内隐秘质粒的方法 |
| US20230232882A1 (en) | 2020-06-05 | 2023-07-27 | Institut National de Recherche Pour I'Agriculture, I'Alimentation et I'Environnement | Use of E. coli strains expressing high level of alpha-Gal to modulate immunity and provide protection against infectious diseases in animals |
| CN111850026A (zh) * | 2020-08-07 | 2020-10-30 | 南开大学 | 一种利用整合自杀载体高效特异性清除细菌中质粒的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4686184A (en) * | 1983-07-01 | 1987-08-11 | Lubrizol Genetics, Inc. | Gene transfer vector |
| DE19713543B4 (de) * | 1997-04-02 | 2007-01-11 | Pharma-Zentrale Gmbh | Bakterielle Plasmide |
| DE19751907B4 (de) * | 1997-11-22 | 2004-07-08 | Pharma-Zentrale Gmbh | Verwendung von Escherichia coli Stamm DSM 6601 zur Behandlung von Diarrhoeen auf dem Veterinärsektor |
| NZ516737A (en) * | 1999-06-22 | 2003-10-31 | Invitrogen Corp | Rapid growing microorganisms for biotechnology applications |
| DE10013539B4 (de) * | 2000-03-20 | 2006-07-13 | Pharma-Zentrale Gmbh | Lipopolysaccharide aus Escherichia coli, Verfahren zu deren Herstellung und deren Verwendungen |
-
2003
- 2003-06-26 DE DE10328669A patent/DE10328669B4/de not_active Expired - Fee Related
-
2004
- 2004-06-25 CN CNB2004800009157A patent/CN100395328C/zh not_active Expired - Fee Related
- 2004-06-25 PT PT04740297T patent/PT1636389E/pt unknown
- 2004-06-25 US US10/525,558 patent/US7993902B2/en not_active Expired - Fee Related
- 2004-06-25 AT AT04740297T patent/ATE412072T1/de active
- 2004-06-25 AU AU2004249888A patent/AU2004249888B2/en not_active Ceased
- 2004-06-25 DK DK04740297T patent/DK1636389T3/da active
- 2004-06-25 TW TW093118600A patent/TWI284150B/zh not_active IP Right Cessation
- 2004-06-25 JP JP2006516056A patent/JP2009514506A/ja active Pending
- 2004-06-25 DE DE502004008323T patent/DE502004008323D1/de not_active Expired - Lifetime
- 2004-06-25 SI SI200430907T patent/SI1636389T1/sl unknown
- 2004-06-25 WO PCT/EP2004/006886 patent/WO2004113575A1/de active Application Filing
- 2004-06-25 CA CA2496080A patent/CA2496080C/en not_active Expired - Fee Related
- 2004-06-25 KR KR1020057003401A patent/KR100654029B1/ko not_active IP Right Cessation
- 2004-06-25 PL PL04740297T patent/PL1636389T3/pl unknown
- 2004-06-25 NZ NZ541192A patent/NZ541192A/en not_active IP Right Cessation
- 2004-06-25 ES ES04740297T patent/ES2314407T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP04740297A patent/EP1636389B1/de not_active Expired - Lifetime
-
2005
- 2005-02-10 ZA ZA2005/01194A patent/ZA200501194B/en unknown
- 2005-02-23 IL IL167067A patent/IL167067A/en not_active IP Right Cessation
-
2006
- 2006-01-04 HK HK06100109.2A patent/HK1079994B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1636389A1 (de) | 2006-03-22 |
| ATE412072T1 (de) | 2008-11-15 |
| AU2004249888A1 (en) | 2004-12-29 |
| HK1079994B (zh) | 2009-02-06 |
| CA2496080C (en) | 2010-01-26 |
| NZ541192A (en) | 2007-02-23 |
| EP1636389B1 (de) | 2008-10-22 |
| US20060094117A1 (en) | 2006-05-04 |
| KR20050093757A (ko) | 2005-09-23 |
| ES2314407T3 (es) | 2009-03-16 |
| TWI284150B (en) | 2007-07-21 |
| CN1700925A (zh) | 2005-11-23 |
| PL1636389T3 (pl) | 2009-06-30 |
| IL167067A (en) | 2010-04-29 |
| CA2496080A1 (en) | 2004-12-29 |
| WO2004113575A1 (de) | 2004-12-29 |
| AU2004249888B2 (en) | 2006-10-26 |
| SI1636389T1 (sl) | 2009-02-28 |
| TW200513530A (en) | 2005-04-16 |
| DE10328669A1 (de) | 2005-02-03 |
| DE10328669B4 (de) | 2005-12-01 |
| US7993902B2 (en) | 2011-08-09 |
| DE502004008323D1 (de) | 2008-12-04 |
| ZA200501194B (en) | 2005-10-26 |
| CN100395328C (zh) | 2008-06-18 |
| JP2009514506A (ja) | 2009-04-09 |
| HK1079994A1 (en) | 2006-04-21 |
| PT1636389E (pt) | 2008-12-26 |
| KR100654029B1 (ko) | 2006-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0130341D0 (en) | Compounds | |
| WO2003016282A3 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| IL175512A0 (en) | Methods of preparing aripiprazole crystalline forms | |
| TNSN05254A1 (en) | Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics | |
| NO20091976L (no) | Nye forbindelser | |
| BRPI0414599A (pt) | pirrol-indóis substituìdos | |
| MXPA04008772A (es) | Composiciones de clorhidrato de naltrexona. | |
| MY135233A (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials | |
| RS20060250A (en) | 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, method for the production thereof, and their use as antiphlogistics | |
| WO2004047879A3 (en) | Antimicrobial lenses, processes to prepare them and methods of their use | |
| WO2003082208A8 (en) | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | |
| PL371127A1 (pl) | Pochodne 6-amino-morfinianu, metody ich otrzymywania oraz ich zastosowania | |
| PL1668001T3 (pl) | Podstawione heteroarylobenzofuranowe kwasy | |
| WO2004007664A3 (en) | Nucleic acid vectors | |
| TW200504402A (en) | Antimicrobial lenses, processes to prepare them and methods of their use | |
| HK1079994A1 (en) | Plasmid-free clone of E coli strain DSM 6601 | |
| TW200510323A (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
| MXPA02012400A (es) | Heterociclos hetaril-substituidos. | |
| SG146640A1 (en) | Isolated photoprotein mtclytin, and use thereof | |
| GB0309440D0 (en) | Quinolone derivatives | |
| MXPA03010613A (es) | Benzoilpirazoles substituidos con actividad herbicida. | |
| MY122950A (en) | Photochromic oxazine compounds and methods for their manufacture | |
| WO2005035643A3 (en) | Inorganic antiblock | |
| NO20053829D0 (no) | Fremgangsmate og intermediater for fremstilling av olanzapin. | |
| AU2003272083A1 (en) | Salt of 6-(1, 3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid with n, n-dimethyl-imidodicarbonimidic diamide |